Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Whayoung Lee, Yuko Miyagawa, Cassandra Long, Matthew Zhang, David K. C. Cooper & Hidetaka Hara. (2016) Effect of Rho-kinase Inhibitor, Y27632, on Porcine Corneal Endothelial Cell Culture, Inflammation and Immune Regulation. Ocular Immunology and Inflammation 24:5, pages 579-593.
Read now
Read now
Jeong Goo Lee & Martin Heur. (2014) Interleukin-1β-Induced Wnt5a Enhances Human Corneal Endothelial Cell Migration through Regulation of Cdc42 and RhoA. Molecular and Cellular Biology 34:18, pages 3535-3545.
Read now
Read now
Articles from other publishers (17)
Audrey J. Weber, Ashley B. Adamson, Kelsey M. Greathouse, Julia P. Andrade, Cameron D. Freeman, Jung Vin Seo, Rosaria J. Rae, Courtney K. Walker & Jeremy H. Herskowitz. (2021) Conditional deletion of ROCK2 induces anxiety-like behaviors and alters dendritic spine density and morphology on CA1 pyramidal neurons. Molecular Brain 14:1.
Crossref
Crossref
Audrey J. Weber & Jeremy H. Herskowitz. (2021) Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Vasudha Abbhi & Poonam Piplani. (2020) Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility. Current Medicinal Chemistry 27:14, pages 2222-2256.
Crossref
Crossref
Kelsey M. Greathouse, Benjamin W. Henderson, Erik G. Gentry & Jeremy H. Herskowitz. (2019) Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors. Behavioural Brain Research 373, pages 112083.
Crossref
Crossref
Adrian Julian Marcus, Igor Iezhitsa, Renu Agarwal, Pavel Vassiliev, Alexander Spasov, Olga Zhukovskaya, Vera Anisimova & Nafeeza Mohd Ismail. (2019) Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension. European Journal of Pharmacology 850, pages 75-87.
Crossref
Crossref
Cherng-Ru Hsu, Yi-Hsun Chen, Chih-Peng Liu, Chih-Hung Chen, Kuo-Kuei Huang, Jui-Wen Huang, Meng-Nan Lin, Chih-Lung Lin, Wan-Ru Chen, Yi-Ling Hsu, Tze-chung Lee, Shuen-Hsiang Chou, Chia-Mu Tu, Chrong-Shiong Hwang, Yu Chuan Huang & Da-Wen Lu. (2019) A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia. Investigative Opthalmology & Visual Science 60:2, pages 624.
Crossref
Crossref
Kelsey M. Greathouse, Benjamin D. Boros, Josue F. Deslauriers, Benjamin W. Henderson, Kendall A. Curtis, Erik G. Gentry & Jeremy H. Herskowitz. (2018) Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity. Brain Structure and Function 223:9, pages 4227-4241.
Crossref
Crossref
Peter X. Shaw, Alan Sang, Yan Wang, Daisy Ho, Christopher Douglas, Lara Dia & Jeffrey L. Goldberg. (2017) Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Experimental Eye Research 158, pages 33-42.
Crossref
Crossref
Hiroshi YamadaMasahiko YonedaShingo InagumaMasahiko GoshoYusuke MurasawaZenzo IsogaiMasahiro Zako. (2017) A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis. Journal of Ocular Pharmacology and Therapeutics 33:3, pages 176-185.
Crossref
Crossref
K.M. Coxon, M. Pahlitzsch, B.M. Davis, J. Duggan, L. Guo & M.F. Cordeiro. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Karen Y. Torrejon, Ellen L. Papke, Justin R. Halman, Magnus Bergkvist, John Danias, Susan T. Sharfstein & Yubing Xie. (2016) TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor. Scientific Reports 6:1.
Crossref
Crossref
Alon Skaat, Jessica V. Jasien & Robert Ritch. (2016) Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma. Journal of Glaucoma 25:9, pages e807-e814.
Crossref
Crossref
Ganesh Prasanna, Byron Li, Muneto Mogi & Dennis S. Rice. (2016) Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?. European Journal of Pharmacology 787, pages 47-56.
Crossref
Crossref
Tanuj Dada, Parul Ichhpujani, Srinivasan Senthilkumari & Alain Bron. 2016. Pharmacology of Ocular Therapeutics. Pharmacology of Ocular Therapeutics
207
227
.
Jeremy Green, Jingrong Cao, Upul K. Bandarage, Huai Gao, John Court, Craig Marhefka, Marc Jacobs, Paul Taslimi, David Newsome, Tomoko Nakayama, Sundeep Shah & Steve Rodems. (2015) Design, Synthesis, and Structure–Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors. Journal of Medicinal Chemistry 58:12, pages 5028-5037.
Crossref
Crossref
Robert N Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini, Jason L Vittitow, Kuldev Singh & Paul L Kaufman. (2015) A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study. British Journal of Ophthalmology 99:6, pages 738-745.
Crossref
Crossref
Sergey Yur'yevich Petrov, Nataliya Nikolaevna Podgornaya, Anna Eduardovna Aslamazova & Dar'ya Maksimovna Safonova. (2015) Biomechanical studies of the iris and the trabecular meshwork. Ophthalmology Reports 8:1, pages 69-78.
Crossref
Crossref